Introduction: Schizophrenia affects between 0.3% and 2% of the worldwide population. A genetic contribution has been postulated in the development of this disorder. Genes such as ApoE have been implicated in the neurodevelopment associated with schizophrenia in case-control and meta-analysis studies, but the results remain inconclusive. Due to this, the aim of the present study was to explore the association between ApoE and schizophrenia through a meta-analysis.
Introduction
Schizophrenia is a complex genetic disorder which may involve multiple small-effect genes (Chen et al., 1999 (Chen et al., , 2015 Fernández et al., 1999; Joober et al., 1996; Thibaut et al., 1999; Tovilla-Zárate et al., 2013) . In this regard, apolipoprotein E (ApoE) is a gene most commonly associated in the field of global genetic analysis with the identification of markers that may help with the diagnosis of the disease or with some indication concerning this pathology (Harrington et al., 1995; Liu et al., 2003; Sorbi et al., 1998; Tovilla-Zárate et al., 2009) . ApoE is a lipid transport associated protein of 34 kD; it is the product of a single gene located at chromosome 19q13.2 locus. This protein codes for 3 common isoforms: ε2, ε3 and ε4 (Durany et al., 2000; Kampman et al., 2004; Kimura et al., 2000; Vila-Rodríguez et al., 2011) , due to cysteine-arginine interchanges at residue 112. These changes in amino acids result from two single nucleotide polymorphisms of the ApoE gene at nucleotides 334 and 472 Martorell et al., 2001; Saiz et al., 2002; Zhu et al., 1996) . Furthermore, these 2 polymorphisms induce complex biological functions which may precipitate the symptoms of psychiatric illnesses (Kecmanovic et al., 2010; Lan et al., 1997; Lee et al., 2001; Moberg et al., 2006) . The study of the ApoE gene and schizophrenia started with the study of Harrington et al. (1995) in which the authors reported that the frequency of allele ε4 was associated with schizophrenia. Subsequently, further studies revealed possible effects of this gene on clinical variables of the illness (Arnold et al., 1997; Dean et al., 2003; Kimura et al., 1997) . However, these findings have been challenged by studies that have failed to show any changes in allele frequency of the ApoE gene in schizophrenia (Akanji et al., 2009; Chee and Salina, 2014; Chen et al., 2015; Jonsson et al., 1996; Schurhoff et al., 2003; Thibaut et al., 1998; Town et al., 1997) . Despite these extensive studies concerning ApoE gene and schizophrenia, the association between them remains unclear. To address this problem, our aim was to perform a meta-analysis and systematic review in which we collected and catalogued all genetic association studies published in the field of schizophrenia and ApoE to investigate whether a genetic risk factor could be associated with the development of the disease.
Methods

Systematic review and meta-analysis
The systematic review and meta-analysis complied with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria (Moher et al., 2009; Swartz, 2011) .
Identification and selection of publications
To identify studies eligible for meta-analysis and systematic review we surveyed PubMed and EBSCO databases. The reports were searched with the keywords "ApoE and schizophrenia". Also, these keywords were employed to find summaries. In addition, studies had to meet the following criteria: (1) to be published in peer-reviewed journals; (2) to present original data on ApoE genotype frequencies in patients with schizophrenia (3) to contain independent data from other studies; (4) to be case-control studies; (5) to use healthy subjects as controls and schizophrenics as patients, and (6) to be written in English.
Inclusion criteria were determined by two researchers (TBGC and YHD), working independently. When the researchers were in disagreement a third researcher (CATZ) was consulted.
Data extraction
For the systematic review, after relevant studies were identified, data extraction was carried out by the same two researchers working independently, though in the end a consensus was reached. From the included studies the following data were extracted and analyzed: authors, year of publication, region, ethnical origin, sample size, number of cases and controls, gender, age, psychiatric diagnosis and genotype and allele frequencies.
The meta-analysis was constructed based on 4 categories: (1) exposed sick, (2) exposed not sick, (3) not exposed sick, and (4) not exposed not sick. The term "sick" stands for schizophrenia patients and the term "exposed" refers to the risk allele.
Data analysis
For the systematic review and meta-analysis the studies deemed for inclusion were scored using the Newcastle-Ottawa Assessment Scale (NOS) ( Table 1) . A score of 6 was considered the cut-off point for high quality. To give more support to our analysis, we also considered the Grading of Recommendations Assessment, Development and Evaluation Scale (GRADES) procedures (http://www.gradeworkinggroup. org; Table 2 ).
The meta-analysis was performed using the EPIDAT 3.1 program (Software for Epidemiologic Analysis of Tabulated Data; http://dxsp. sergas.es). In all the analyses we used the random effects model as previously reported (González-Castro et al., 2013a ,b, 2014a . Initially, we measured the heterogeneity of the sample using the Dersimonian and Laird Q test supported by graphs to help with the visualization of the studies that affected heterogeneity. We presented the outcomes expressed as odds ratios (ORs). For the ApoE gene, ORs were calculated for each model used, viz.: ε4 vs ε3, ε4 vs ε2, and ε4 carriers vs ε3 + ε2 non-carriers. To address publication bias we used Egger's test and funnel plots in the same software. We performed a sensitivity analysis and the influence of each study on global estimation was analyzed and graphed. Also, we used the Pearson's χ 2 test to measure the Hardy-Weinberg equilibrium and genotype distribution to assess goodness of fit.
Results
Description of the studies
The search strategy retrieved 188 potentially relevant studies, but after discarding duplicates and not valuable data according to the inclusion criteria, 28 reports remained for the analysis (Akanji et al., 2009; Arnold et al., 1997; Chen et al., 1999; Dean et al., 2003; Durany et al., 2000; Fernández et al., 1999; Harrington et al., 1995; Igata-Yi et al., 1997; Jonsson et al., 1996; Joober et al., 1996; Kampman et al., 2004; Kecmanovic et al., 2010; Kimura et al., 1997 Kimura et al., , 2000 Lan et al., 1997; Lee et al., 2001; Liu et al., 2003; Martorell et al., 2001; Moberg et al., 2006; Saiz et al., 2002; Schurhoff et al., 2003; Sorbi et al., 1998; Thibaut et al., 1998 Thibaut et al., , 1999 Tovilla-Zárate et al., 2009; Town et al., 1997; Vila-Rodríguez et al., 2011; Zhu et al., 1996) . Fig. 1 shows the flowchart illustrating the selection of the studies. In addition, the articles included in this analysis are shown in Fig. 2 by year of publication. From these 28 reports, 19 studies were carried out in Caucasians, 7 in Asians and 2 in other populations. As a result, we conducted a meta-analysis with 4703 controls and 3452 schizophrenics. The Hardy-Weinberg equilibrium (HWE) was measured in all the included studies and also in a pool made of the results from all the studies (combined data; Table 3 ).
Meta-analysis
First, we evaluated the interaction of ApoE with schizophrenia in all the populations of the studies included in this work. We measured the role of this gene in three models (Table 4; Figs. 3 and 4) . In the first model, ε4 vs ε3, the combined ORs and 95% CI showed that ApoE did not increase significantly the risk for schizophrenia [OR 0.95; 95% CI (Figs. 9 and 10) . Our results as a whole suggest that ApoE ε3 could be a protective factor in the Asian population.
With regard to the Caucasian population, 19 studies were evaluated which did not present heterogeneity (Table 4) . Combined ORs and 95% CI yielded no association between ApoE and schizophrenia in this population after using the following the models: ε4 vs ε3 [OR 1.14; 95% CI 
Discussion
ApoE is an essential enzyme in the modulation of cholesterol and phospholipid transport among cells, but even more important is the fact that this protein is produced by astrocytes where it plays a vital role in growth and regeneration of neurons during development. Initially, this issue drew the interest of Harrington et al. (1995) who analyzed the participation of the ApoE gene in the pathology of schizophrenia. Since then, several researchers have focused their attention on the interaction of allele ε4 as major risk factor in schizophrenics, though the results of the studies have been contrasting (Dean et al., 2003; Kimura et al., 2000; Tovilla-Zárate et al., 2009 ). Therefore, our aim was to evaluate this association in a systematic review and meta-analysis to determine the role of this gene using available published data.
Our analysis showed a relationship when we analyzed the ApoE gene in Asian populations using models ε4 vs ε3 [OR 0.72; 95% CI (0.52-0.98)] and ε4 vs ε3 + ε2 [OR 0.66; 95% CI (0.50-0.88)]. The obtained outcomes suggest a possible protective effect of allele ε3 to present a schizophrenic disorder. In this sense, some studies have determined that the allelic distribution of ApoE gene depends on the ethnic origin of the sample (Seixas et al., 1999) . For example, in the study of Corbo and Scacchi (1999) , the authors describe that the allele distribution has a strongly marked difference between the Chinese population and American or European whites. As a result, when we analyzed the Caucasian population, we divided it in two groups Americans and Europeans, but we did not find any association with schizophrenia.
We recommend to take these results with caution because it is necessary to make further analyses using larger samples and to perform an ancestral analysis. Moreover, we have observed that most of the population of schizophrenic patients analyzed is male; this result is interesting given that gender differences have been reported to influence schizophrenia. For example, Schurhoff et al. (2003) reported an association between ApoE ε2ε3 genotypes and male schizophrenic patients. They also mentioned that ApoE ε2 may have a protective effect only in women. Therefore, the ApoE variant may modulate its phenotypic expression in a sex-dependent manner (Martorell et al., 2001) . In order to have conclusive results, we suggest that more studies must be undertaken to investigate this association.
This evidence must be taken with caution. First, not only the ApoE allele distribution is affected by the ethnic origin of the sample, but also it has been proposed that the ethnic origin may influence the expression of this gene. On the other hand, there is the possibility that the interaction of a hypothetic gene may be playing a role in the distribution of the ApoE gene and its effects on schizophrenia. Furthermore, ApoE could be a predisposing gene, which may exert a small effect on the development of schizophrenia in some populations. It is possible that previous studies reporting a null association could be due to the small size of the sample studied. This assumption must be considered because, in the present meta-analysis, 16 of the 28 studies included less than 200 subjects (Table 3) .
We want to emphasize the existence of 3 previous meta-analyses (Schurhoff et al., 2003; Tovilla-Zárate et al., 2008; Xu et al., 2006) of the ApoE gene, but 2 of them did not focus their analyses in assessing Fig. 3 . Odds ratios and forest plots of ApoE in overall studies with heterogeneity, using the following models: A) ε4 vs ε3 and B) ε4 vs ε3 + ε2.
the interaction by population. Hence further studies with larger samples as the present one are required to get more conclusive results. In addition, these previous meta-analyses evaluated only the interaction of ε4 carriers vs non-carriers and not of all the alleles tested independently; this is the strength of our present work. On other hand, although ApoE was not found as risk factor in schizophrenics compared to controls, we still consider the possibility that ApoE may affect in some way the expression of the disease. Our data present several limitations. This sample is not large enough, and it is possible that the statistical power is not enough to detect small effects of the ApoE gene, so no definitive conclusions can be drawn. On the other hand, to ensure that our meta-analysis excluded poorly designed studies, we selected only published reports. Also, the period of publication is short. In consequence, it is necessary to evaluate this information with new available data. Alternatively, we did not analyze endophenotypes that could be involved in schizophrenics; we believe unlikely that diagnostic features in the classification of schizophrenics can represent a serious problem. Finally, because many data were incomplete and we could not obtain the information from the authors, we did not perform sub-analyses with potentially confounder factors such as gender, age and lifestyle, among others.
In conclusion, our findings suggest that allele ε3 may have a protective association to present schizophrenia in Asian populations. However, it is probable that the ApoE gene exerts a small effect. Therefore, it is necessary to carry out further studies with a larger number of patients and new data to gain a better understanding into the role of the ApoE gene in the development of schizophrenia.
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The authors declare not to have any conflict interest. . Odds ratios and forest plots of ApoE in overall studies, without heterogeneity, using the following models: A) ε4 vs ε3; B) ε4 vs ε2 and C) ε4 vs ε3 + ε2.
Fig. 6.
Egger's funnel plots indicating publication bias in all the studies on schizophrenics and ApoE, without heterogeneity, using the following models: A) ε4 vs ε3; B) ε4 vs ε2 and C) ε4 vs ε3 + ε2. Fig. 7 . Odds ratios and forest plots of ApoE in Asian population studies, with heterogeneity, using the following models: A) ε4 vs ε3 and B) ε4 vs ε3 + ε2. Fig. 9 . Odds ratios and forest plots of ApoE in Asian population studies, without heterogeneity, using the following models: A) ε4 vs ε3; B) ε4 vs ε2 and C) ε4 vs ε3 + ε2.
Fig. 10.
Egger's funnel plots indicating publication bias in Asian population studies, without heterogeneity, using the following models: A) ε4 vs ε3; B) ε4 vs ε2 and C) ε4 vs ε3 + ε2. Fig. 11 . Odds ratios and forest plots of ApoE in Caucasian population studies, without heterogeneity, using the following models: A) ε4 vs ε3; B) ε4 vs ε2 and C) ε4 vs ε3 + ε2.
Fig. 12.
Egger's funnel plots indicating publication bias in Caucasian population studies, without heterogeneity, using the following models: A) ε4 vs ε3; B) ε4 vs ε2 and C) ε4 vs ε3 + ε2.
